Advertisement

Related Videos

R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA, on Alternative Dispensing Strategies

Mark J. Ratain, MD: The Justification for a Randomized Trial of Low-Dose Ibrutinib

Garth Strohbehn, MD, MPhil, on Applied Clinical Pharmacology in a Crisis: Interventional Pharmacoeconomics and COVID-19

CS Pramesh, MS, FRCS, on Opportunities in India: A Perspective From a Low-Middle Income Country

Deborah Collyar: What's In It for Patients?

Advertisement

Advertisement




Jul
30
Today In Oncology
Germline Genetic Variants Associated With CAR T-Cell Therapy Safety and Efficacy in Hematologic Malignancies
FDA Approves SimpleScreen CRC Blood-Based Screening Test for Colorectal Cancer
MMUD vs MRD Transplantation in the Posttransplant Cyclophosphamide Era
Global Breast Cancer Survival Estimates: WHO Analysis
Concurrent Palliative Care Remains Underused Among Young Adults With Advanced Cancer
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo